Cancer and Diagnostics

Cancer Biopsy

Researchers are encouraged to submit abstracts for the "Cancer Biopsy" track at the "World Cancer 2024" conference, focusing on advancements in biopsy techniques, biomarker analysis, and their role in cancer diagnosis and treatment decision-making. Abstracts should highlight innovative biopsy methodologies, molecular profiling techniques, and their clinical applications in various cancer types.

Attendees can expect presentations on the latest developments in minimally invasive biopsy procedures, such as liquid biopsies, circulating tumor cells, and tissue microsampling techniques. Discussions will cover the utility of biopsy-derived biomarkers in predicting treatment response, monitoring disease progression, and guiding therapeutic decisions.

The track will also feature sessions on biopsy specimen handling, processing, and analysis methodologies, as well as discussions on the integration of biopsy findings into personalized cancer care pathways. Attendees will have the opportunity to engage with leading experts, share insights, and explore collaborative opportunities to advance the field of cancer biopsy and its impact on patient outcomes.